FOx Biosystems

Temse, Belgium Founded: 2017 • Age: 9 yrs
Developer of fiber optic bio-sensing technology based on surface plasmon resonance

About FOx Biosystems

FOx Biosystems is a company based in Temse (Belgium) founded in 2017. FOx Biosystems has raised $4.53 million across 3 funding rounds from investors including KU Leuven, European Union and EIC Fund. The company has 9 employees. FOx Biosystems operates in a competitive market with competitors including Carterra, Nicoya Life, Riot Platforms, Pharma Diagnostics and Plasmore, among others.

  • Headquarter Temse, Belgium
  • Employees 9
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website foxbiosystems.com
  • Social LinkedIn
Key Metrics
  • Total Equity Funding
    $4.53M (USD)

    in 3 rounds

  • Latest Funding Round
    $2.84M (USD), Grant

    Dec 2022

  • Investors
    KU Leuven

    & 3 more

  • Employee Count
    9

Funding Insights of FOx Biosystems

FOx Biosystems has successfully raised a total of $4.53M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $2.84 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.53M
  • Total Rounds 3
  • Last Round Grant β€” $2.84M
  • First Round $4.53M

    (Feb 2019)

  • Investors Count 4

All 3 funding rounds of FOx Biosystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2022$2.84MGrant––
Mar 2021$308,671Grant––
Feb 2019$4.53MSeries A–LRM, KU Leuven
–
Valuation history

4 investors in total: 4 institutional.

Investors in FOx Biosystems

FOx Biosystems has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include KU Leuven, European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
–eicfund.euBrussels, Belgium
LRM is engaged in providing risk capital and smart money to businesses in Limburg.
–lrm.beHasselt, Belgium
Higher education is delivered through diverse courses and degrees.
1425kuleuven.beLeuven, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for FOx Biosystems

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of FOx Biosystems

3 dated milestones of FOx Biosystems across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded FOx Biosystems is founded.
  2. Funding First funding round of $4.5M.
  3. Funding Latest funding round, Grant, of $2.8M.

Competitors of FOx Biosystems

FOx Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Carterra, Nicoya Life, Riot Platforms, Pharma Diagnostics and Plasmore, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
carterra-bio.com2004Salt Lake, United States$47.22M–
SPR-based platforms are developed for enzyme kinetics studies.
nicoyalife.com2012Kitchener, Canada$27.54M–
Hyperspectral optical microscopes for surface analysis are provided.
riotplatforms.com2000Castle Rock, United States–3
Bitcoin mining solutions are offered by the platform.
pharmadiagnostics.com2007Asse, Belgium$7.4M8
Biomolecular interactions are analyzed via plate-based LSPR assays.
plasmore.com2009Pavia, Italy––
Develops nanoplasmon imaging technology
smartdrop.co.kr2014Seongnam-si, South Korea––
Electronic devices for interface contact angle measurement are provided.
affiniteinstruments.com2015Montreal, Canada––
A portable SPR platform for molecular analysis is developed.
episentum.com2010Upplands Vasby, Sweden––
Label-enhanced surface plasmon resonance biosensors are developed for enhanced detection.
biosensingusa.com2015Tempe, United States––
Surface analytical instruments for life sciences and materials applications
Premium access

Detailed competitors of FOx Biosystems

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to FOx Biosystems

10 companies that operate in the same segment as FOx Biosystems (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about FOx Biosystems

FOx Biosystems was founded in 2017 and raised its 1st funding round 2 years after it was founded.

FOx Biosystems is headquartered in Temse, Belgium. It is registered at Temse, East Flanders, Belgium.

FOx Biosystems is a funded company, having raised a total of $4.53M across 3 funding rounds to date. The company's 1st funding round was a Series A of $4.53M, raised on Feb 2019.

FOx Biosystems has 9 employees.

FOx Biosystems was established in 2017 as a spin-off from KU Leuvens MeBioS Biosensor group and is based in Temse, Belgium. Fiber optic biosensing technology utilizing surface plasmon resonance is provided for biomolecular interaction analyses in the biotech sector. The White Fox 1.0 instrument is applied to quantify specific proteins, small molecules, and elements in cellular bioreactor development, DNA, or cell studies within microliter volumes.

FOx Biosystems's top competitors include Carterra, Nicoya Life and Riot Platforms.

FOx Biosystems has 4 investors. Key investors include KU Leuven, European Union, EIC Fund, and LRM.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available